Speaker Profile
Ph.D., Principal, Policy Development - Emerging Science, ACS CAN
Biography
Dr. Mark Fleury specializes in research, drug development, and regulatory policies along with other science and technology related projects. He has worked extensively on reform of diagnostic testing oversight, helped lead a coalition authored a landscape report on drug development challenges in pediatric cancer, and led another coalition that created a report and recommendations focused on overcoming cancer clinical trial enrollment barriers. He currently sits on the steering committee of the Targeted Agent and Profiling Utilization Registry (TAPUR) Study, which examines the use of targeted anticancer agents used off-label in clinical settings and is the principle investigator on a clinical trial assessing enhanced trial eligibility screening processes. Throughout his work, Mark has striven to incorporate patient perspectives on to inherently science-based issues, advocating for the inclusion of patients as partners throughout the bench to bedside translation of science.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair:
Kristine Ashcraft, YouScript
Program Theme: Addressing Persistent PGx Myths
- PMWC Award Ceremony:
Luminary Honoree: Philip E. Empey, UPMC
Pioneer Honoree: Collen Masimirembwa, University of the Witwatersrand
- Keynote: Genomic Diversity in Africa: Pharmacogenetics and Clinical Applications
- Collen Masimirembwa, University of the Witwatersrand
- PGx is Expensive and Insurance Coverage is Limited (PANEL)
Chair: Jai Patel, Atrium Health
- Lena Chaihorskym, Alva10
- Mark Fleury, ACS CAN
- Kristin Wiisanen, Rosalind Franklin University
- Alison L. Quinn, Kaiser - Science Backing PGx is Limited (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Russ Altman, Stanford
- Philip E. Empey, UPMC
- PGx is Hard to Implement (PANEL)
Chair: Kristine Crews, St Jude
- Suzanne Stevens, Wentworth-Douglass Hospital
- Deepak Voora, VA
- Jason Roos, ARPA-H
- Jennifer Wick, The Christ Hospital Health Network
- What will It Take to Make PGx the Standard of Care? (PANEL)
Chair: Kristine Ashcraft, YouScript
- Alan Venook, UCSF/ NCCN
- Gary Marchant, ASU
- Dan Hertz, University of Michigan
- Deepak Voora, VA
